Development of membrane protein-based vaccine against lumpy skin disease virus (LSDV) using immunoinformatic tools.

Thus, the present findings may indicate that the engineered multi-epitope vaccine is structurally stable and can induce a strong immune response, which should help in developing an effective vaccine towards controlling LSDV infection.